Navigation Links
Omeros Corporation Reports Third Quarter 2013 Financial Results
Date:11/7/2013

FDA for the treatment of Huntington's disease.
  • Reported positive clinical data from its Phase 1 clinical trial of OMS721, the company's lead human monoclonal antibody targeting mannan-binding lectin-associated serine protease-2 (MASP-2), an important regulator of the lectin pathway of the immune system. A Phase 2 clinical program to evaluate OMS721 in the treatment of thrombotic microangiopathies (TMAs), a family of disorders that occurs in the microcirculation of the body's organs, most commonly the kidney and brain, is expected to begin enrollment in early 2014.
  • Announced that its proprietary Cellular Redistribution Assay technology had "unlocked" six additional Class A orphan G protein-coupled receptors (GPCRs) for drug development, bringing the total number of Class A orphan GPCRs "unlocked" by Omeros to 52. These six orphan GPCRs are linked to a series of important indications, including cardiovascular indications, certain types of cancer and Grave's disease. Omeros also announced that it had identified small molecules that interact with two non-orphan Class B GPCRs, the glucagon-like peptide 1 receptor (GLP-1R) and the parathyroid hormone 1 receptor (PTH-1R). Both of these receptors are established drug targets – GLP-1R for diabetes and PTH-1R for osteoporosis.
  • Financial ResultsTotal operating expenses for the quarter ended September 30, 2013 were $13.6 million and included non-cash expenses of $3.2 million related to rent expense and stock-based compensation. For the same period in 2012, total operating expenses were $14.5 million, which included non-cash rent and stock-based compensation expenses of $576,000.

    The decrease in total operating expenses for the quarter ended September 30, 2013 compared to the prior year quarter is primarily due to a litigation settlement expense of $3.95 million recorded in the same period in 2012, which was reimbursed by CCIC in the fourth quarter of 2012. For the quarter ended Septemb
    '/>"/>

    SOURCE Omeros Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related biology technology :

    1. Omeros Announces Closing of $16.2 Million Registered Direct Offering of Common Stock
    2. Omeros to Present at the 12th Annual Needham Healthcare Conference
    3. Omeros Corporation Reports Fourth Quarter and Year-End 2012 Financial Results
    4. Omeros Announces Enrollment in Phase 1 Clinical Trial Evaluating OMS824
    5. Omeros to Present at the 19th Annual Newsmakers in the Biotech Industry Conference
    6. Omeros Has Now Unlocked Over Half of the Class A Orphan GPCRs
    7. Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs
    8. Omeros Announces It Has Unlocked Over 20 Percent of Class A Orphan GPCRs
    9. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2014 Financial Results
    10. Attention Amarin Corporation plc Investors: Amarin Corporation plc Misled Investors According to a Newly Filed Class Action
    11. General Patent Corporation Chairman and CEO Alexander Poltorak Joins Spherix Board Industry veteran and authority on patent law and valuation joins Spherix as director
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/29/2014)... 29, 2014 Burnham Securities Inc. ("Burnham"), ... ("TCG"), a leader in healthcare venture development and ... alliance to expand the range of services each ... alliance, Burnham Securities will be supported by a ... and management in healthcare industry to build a ...
    (Date:9/29/2014)... ZIONA, Israel , September 29, ... stage company developing novel immunomodulators for severe infections, today ... ( BARDA ) has awarded Atox Bio with a ... for the development of AB103 to treat Necrotizing Soft ... and public health threats that end in sepsis. ...
    (Date:9/29/2014)... 2014 Westbridge Agricultural Products announced ... a highly effective new tool for organic growers. ... spectrum contact herbicide for post-emergent, non-selective weed control ... crops. The formulation is an emulsifiable concentrate that ... Institute (OMRI) for use in organic food production. ...
    (Date:9/27/2014)... interdisciplinary team of University of Pennsylvania researchers has ... sequencing toward measuring other nanoscopic structures. By passing ... in a membrane, the team was able to ... , Their findings suggest new ways of using ... objects at the smallest scale. , The ...
    Breaking Biology Technology:Burnham Securities Inc. and The Channel Group Form Healthcare Alliance 2Burnham Securities Inc. and The Channel Group Form Healthcare Alliance 3Atox Bio Awarded Contract Worth up to $24 Million for the Development of AB103 by the Biomedical Advanced Research and Development Authority (BARDA) 2Westbridge Receives EPA Approval for Its New SUPPRESS™ Herbicide EC 2Penn team studies nanocrystals by passing them through tiny pores 2Penn team studies nanocrystals by passing them through tiny pores 3Penn team studies nanocrystals by passing them through tiny pores 4
    ... ... Processing Leader Applies For Microfluidics Reaction Technology™ (MRT) Patent in Japan , ... Newton, MA ... along with its exclusive Japanese distributor, POWREX Corporation, it has introduced Microfluidics Reaction ...
    ... ... ... offer a live, interactive Webinar on the benefits and value of implementing MODA-EM™, on Tuesday, ... will feature Marvin Thompson, Manager, Quality Operations at Talecris, and Bob Toal, Vice President at ...
    ... ... takes a giant step forward with two industry leading companies creating an integration ... ... 19, 2010 -- The world-class preclinical software developer PDS Pathology Data System (PDS) ...
    Cached Biology Technology:Microfluidics and POWREX Launch Revolutionary Continuous Pharmaceutical Manufacturing Technology in Japan 2Microfluidics and POWREX Launch Revolutionary Continuous Pharmaceutical Manufacturing Technology in Japan 3Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics 2Live Webinar: Paperless QC Micro Implemented by Talecris Biotherapeutics 3Mettler Toledo and PDS Pathology Data Systems Integrate Powerful Solutions for Faster and More Accurate Preclinical Studies 2Mettler Toledo and PDS Pathology Data Systems Integrate Powerful Solutions for Faster and More Accurate Preclinical Studies 3
    (Date:9/29/2014)... 2014 -- Plants have a symbiotic relationship with ... extract nutrients and defend against invaders an ... and vegetables. Now, scientist have discovered that plants ... thus ensuring that sprouting plants are colonized from ... Notre Dame, presented their findings today at the ...
    (Date:9/29/2014)... from 2009, "human activities in this area of the world ... is increasingly grown for use as a cooking oil and ... has become the most widely produced edible oil in the ... that of soybean oil. , The environmental effects of such ... grow the crop, and the preferred method is fire. The ...
    (Date:9/29/2014)... home should use ventilation when cooking with a gas ... a new study showed an association between gas kitchen ... , "In homes where a gas stove was used ... higher than in homes where a gas stove was ... in the College of Public Health and Human Sciences ...
    Breaking Biology News(10 mins):Plants prepackage beneficial microbes in their seeds 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 2Childhood asthma linked to lack of ventilation for gas stoves, OSU study shows 3
    ... previously developed to measure a toxin found in tobacco ... in people suffering from spinal cord injuries and multiple ... The toxin, called acrolein, is produced in the body ... biochemical events thought to worsen the injury,s severity. Acrolein ...
    ... structure called "the microtubule network" is a crucial part ... system within nerve cells, carrying essential proteins and enabling ... and Parkinson,s, this network breaks down, hindering motor abilities ... of Tel Aviv University,s Sackler Faculty of Medicine has ...
    ... PHILADELPHIA (June 13, 2013)Twenty-two of the nation,s most ... Biomedical Sciences by The Pew Charitable Trusts today. ... researching the basis of perplexing health problems such ... new scholars join a prestigious community of researchers ...
    Cached Biology News:Testing method promising for spinal cord injuries, multiple sclerosis 2Testing method promising for spinal cord injuries, multiple sclerosis 3A peptide to protect brain function 2From autism to diabetes to Parkinson's disease 2From autism to diabetes to Parkinson's disease 3